Literature DB >> 16093914

Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice.

Johannes Stegbauer1, Oliver Vonend, Sina Habbel, Ivo Quack, Lorenz Sellin, Volkmar Gross, Lars Christian Rump.   

Abstract

OBJECTIVE: Angiotensin (Ang) II enhances renal sympathetic neurotransmission and stimulates nitric oxide (NO) release. The present study investigates whether Ang II-mediated modulation of sympathetic neurotransmission is dependent on NO production in the kidney. AT2 -/y receptor-deficient mice are used to identify the Ang II receptor subtype involved.
METHODS: Mice kidneys were isolated and perfused with Krebs-Henseleit solution. Drugs were added to the perfusion solution in a cumulative manner. Release of endogenous noradrenaline (NA) was measured by high-performance liquid chromatography (HPLC). AT1 receptor expression was analysed by real-time polymerase chain reaction (PCR).
RESULTS: Ang II (0.01-30 nmol/l) dose dependently increased pressor responses in kidneys of AT2 -/y mice and wild-type (AT2 +/y) mice. Maximal pressor responses and EC50 values for Ang II was greater in AT2 -/y than in AT2 +/y mice. L-NAME (N(omega)-nitro-L-arginine methyl ester; 0.3 mmol/l) enhanced Ang II-induced pressor responses in both strains. In AT2 -/y mice, Ang II-induced facilitation of NA release was more pronounced than in AT2 +/y mice. L-NAME reduced Ang II-mediated facilitation of NA release in both strains. This reduction was more potent in AT2 -/y mice. In kidneys of AT2 -/y mice the AT1 receptor expression was significantly upregulated.
CONCLUSION: These results suggest that activation of AT1 receptors by Ang II releases NO in mouse kidney to modulate sympathetic neurotransmission. Since AT1 receptors are upregulated in AT2 -/y mice kidneys, NO-dependent effects were greater in these mice. Thus, NO seems to play an important modulatory role for renal sympathetic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093914     DOI: 10.1097/01.hjh.0000179763.02583.8e

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

1.  Alpha(2A)-adrenoceptors regulate sympathetic transmitter release in mice kidneys.

Authors:  O Vonend; S Habbel; J Stegbauer; J Roth; L Hein; L C Rump
Journal:  Br J Pharmacol       Date:  2006-11-20       Impact factor: 8.739

2.  RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Winston Thomas; Keith A Hruska; Anthony J Muslin
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

Review 3.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

4.  Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.

Authors:  J Stegbauer; S A Potthoff; I Quack; E Mergia; T Clasen; S Friedrich; O Vonend; M Woznowski; E Königshausen; L Sellin; L C Rump
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 5.  AT2 receptor signaling and sympathetic regulation.

Authors:  Lie Gao; Irving H Zucker
Journal:  Curr Opin Pharmacol       Date:  2010-12-13       Impact factor: 5.547

6.  Regulation of renal sympathetic neurotransmission by renal α(2A)-adrenoceptors is impaired in chronic renal failure.

Authors:  Henning Hoch; Johannes Stegbauer; Sebastian A Potthoff; Lutz Hein; Ivo Quack; Lars Christian Rump; Oliver Vonend
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 7.  Angiotensin II, sympathetic nerve activity and chronic heart failure.

Authors:  Yutang Wang; Sai-Wang Seto; Jonathan Golledge
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

8.  α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease.

Authors:  Lydia Hering; Masudur Rahman; Henning Hoch; Lajos Markó; Guang Yang; Annika Reil; Mina Yakoub; Vikram Gupta; Sebastian A Potthoff; Oliver Vonend; Donna L Ralph; Susan B Gurley; Alicia A McDonough; Lars C Rump; Johannes Stegbauer
Journal:  J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 10.121

9.  Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.

Authors:  S A Potthoff; S Stamer; K Grave; E Königshausen; S H Sivritas; M Thieme; Y Mori; M Woznowski; L C Rump; J Stegbauer
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-07-12       Impact factor: 1.636

10.  Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension.

Authors:  Johannes Stegbauer; Sebastian Friedrich; Sebastian A Potthoff; Kathrin Broekmans; Miriam M Cortese-Krott; Ivo Quack; Lars Christian Rump; Doris Koesling; Evanthia Mergia
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.